Reference values for TREC and KREC concentrations in adults

DOI: https://doi.org/10.29296/25877305-2021-06-05
Download full text PDF
Issue: 
6
Year: 
2021

N. Davydova(1), Candidate of Medical Sciences; Professor A. Prodeus(2), MD; I. Obraztsov(1),
Candidate of Medical Sciences; Professor D. Kudlay(3, 4), MD; I. Korsunsky(1), MD (1)G.N. Speransky City
Children’s Hospital Ninth, Moscow (2)Immanuel Kant Baltic Federal University, Kaliningrad (3)I.M. Sechenov
First Moscow State Medical University (Sechenov University) (4)NRC Institute of Immunology, Federal
Biomedical Agency of Russia, Moscow

The quantitative determination of TREC and KREC levels has found wide application in the diagnosis of primary immunodeficiency in the world pediatric practice. The application of the method in the diagnosis of adult patients has remained poorly understood until now. To determine the reference values of TREC and KREC for patients over 17 years old, 140 people aged 18 to 83 years were examined. As a result, the cutoff of the TREC and KREC concentration were determined for whole blood and dry blood stains in patients of the following age groups: 18–24 years old, 25–44 years old, 45–60 years old and over 60 years old.

Keywords: 
immunodeficiency
TREC
KREC
adults
«B&T-kit»
diagnostics



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Korsunskij I.A., Prodeus A.P., Rumjantsev A.G. i dr. Skrining novorozhdennyh na pervichnye immunodefitsity i gruppu riska immunoreguljatornyh rasstrojstv, trebujuschih dispansernogo nabljudenija. Pediatrija. 2019; 98 (3): 49–54 [Korsunsky I.A., Prodeus A.P., Rumyantsev A.G. et al. Screening of newborns for primary immunodeficiencies and risk groups for immunoregulatory disorders requiring follow-up. Pediatria. 2019; 98 (3): 49–54 (in Russ.)]. DOI: 10.24110/0031-403X-2019-98-3-49-54
  2. Korsunskij I.A., Gordukova M.A., Munblit i dr. Klinicheskie i epidemiologicheskie aspekty pervichnyh immunodefitsitnyh sostojanij i ih rannego obnaruzhenija. Meditsinskaja immunologija. 2017; 19 (5): 505–12 [Korsunskiy I.A. Korsunskiy I.A., Gordukova M.A., Munblit D.B. et al. Clinical and epidemiological aspects of primary immunodeficiency diseases (PID) and early diagnosis options. Medical Immunology (Russia). 2017; 19 (5): 505–12 (in Ryuss.)]. DOI: 10.15789/1563-0625-2017-5-505-512
  3. Korsunskij I.A., Kudlaj D.A., Prodeus A.P. i dr. Neonatal'nyj skrining na pervichnye immunodefitsitnye sostojanija i T-/V -kletochnye limfopenii kak osnova formirovanija grupp riska detej s vrozhdennymi patologijami. Pediatrija im. G.N. Speranskogo. 2020; 99 (2) 8–15 [Korsunsky I.A., Kudlay D.A., Prodeus A.P. et al. Neonatal screening for primary immunodeficiency and T-/B-cell lymphopenia as the basis for the formation of risk groups for children with congenital pathologies. Pediatria n.a. G.N. Speransky. 2020; 99 (2): 8–15 (in Russ.)]. DOI: 10.24110/0031-403X-2020-99-2-8-15
  4. Korsunskiy I. et al. TREC and KREC levels as a predictors of lymphocyte subpopulations measured by flow cytometry. Front Physiol. 2019; 9: 1877. DOI: 10.3389/fphys.2018.01877
  5. Korsunskiy I. et al. Expanding TREC and KREC Utility in Primary Immunodeficiency Diseases Diagnosis. Front Immunol. 2020; 11: 320. DOI: 10.3389/fimmu.2020.00320
  6. Kozlov V.A., Savchenko A.A., Kudrjavtsev I.V. i dr. Klinicheskaja immunologija. Krasnojarsk: Polikor, 2020; 386 s. [Kozlov V.A., Savchenko A.A., Kudryavtsev I.V. et al. Klinicheskaya immunologiya.[Clinical immunology]. Krasnoyarsk, Polikom Publ., 2020; 386 p. (in Russ.)]. DOI: 10.17513/np.438
  7. Mauracher A.A. et al. Causes of low neonatal T-cell receptor excision circles: A systematic review. J Allergy Clin Immunol Pract. 2017; 5 (5): 1457–60.e22. DOI: 10.1016/j.jaip.2017.02.009
  8. Parvaneh N. et al. Primary immunodeficiencies: A rapidly evolving story. J Allergy Clin Immunol. 2013; 131 (2): 314–23. DOI: 10.1016/j.jaci.2012.11.051
  9. Kwok J.S.Y. et al. Establishing Simultaneous T Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) Quantification Assays and Laboratory Reference Intervals in Healthy Individuals of Different Age Groups in Hong Kong. Front Immunol. 2020; 11: 1411. DOI: 10.3389/fimmu.2020.01411
  10. Yi J.S. et al. Establishment of normative ranges of the healthy human immune system with comprehensive polychromatic flow cytometry profiling. PLoS One. 2019; 14 (12): e0225512. DOI: 10.1371/journal.pone.0225512
  11. Gordukova M.A., Oskorbin I.P., Mishukova O.V. i dr. Razrabotka nabora reagentov dlja kolichestvennogo opredelenija molekul DNK TREC i KREC v tsel'noj krovi i suhih pjatnah krovi metodom mul'tipleksnoj PTsR v rezhime real'nogo vremeni. Meditsinskaja immunologija. 2015; 17 (5): 467–78 [Gordukova M.A. Oskorbin I.P., Mishukova O.V. et al. Development of Real-Time Multiplex PCR for the Quantitative Determination of TREC’s and KREC’s in Whole Blood and in Dried Blood Spots. Medical Immunology (Russia). 2015; 17 (5): 467–78 (in Russ.)]. DOI: 10.15789/1563-0625-2015-5-467-478
  12. Mamaev A.N., Kudlaj D.A. Statisticheskie metody v meditsine. M.: Prakticheskaja meditsina, 2021; 136 s. [Mamaev A.N., Kudlay D.A. Statisticheskie metody v meditsine. M.: Prakticheskaya meditsina, 2021; 136 s. (in Russ.)]
  13. Cowan J.E. et al. Postnatal Involution and Counter-Involution of the Thymus. Front Immunol. 2020; 11: 897. DOI: 10.3389/fimmu.2020.00897
  14. Rahikainen A.-L. et al. DNA quality and quantity from up to 16 years old post-mortem blood stored on FTA cards. Forensic Science International. 2016; 261: 148–53. DOI: 10.1016/j.forsciint.2016.02.014
  15. Adekambi T. et al. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest. 2015; 125 (5): 1827–38. DOI: 10.1172/JCI77990
  16. Obraztsov I.V., Gordukova M.A., Severina N.A. i dr. Ekstsizionnye kol'tsa V(D)J-rekombinatsii B- i T-kletok kak prognosticheskij marker pri V-kletochnom hronicheskom limfolejkoze. Klinicheskaja onkogematologija. 2017; 10 (2): 131–40 [Obraztsov I.V., Gordukova M.A., Severina N.A. et al. V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia. Clinical oncohematology. 2017; 10 (2): 131–40 (in Russ.)]. DOI: 10.21320/2500-2139-2017-10-2-131-140
  17. Obraztsov I.V., Gordukova M.A., Tsvetkova E.V. i dr. Ekstsizionnye kol'tsa V(D)J rekombinatsii B- i T-kletok kak pokazateli immunologicheskoj rekonstitutsii u detej s ostrym limfoblastnym lejkozom. Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2016; 15 (4): 42–50 [Obraztsov I.V., Gordukova M.A., Tsvetkova E.V. et al. B- and T-cell V(D)J-recombination excision circles as indicators of immunological reconstitution in children with acute lymphoblastic leukemia. Pediatric Hematology/Oncology and Immunopathology. 2016; 15 (4): 42–50 (in Russ.)]. DOI: 10.24287/1726-1708-2016-15-4-42-50
  18. Douek D.C. et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998; 396 (6712): 690–5. DOI: 10.1038/25374